Vanguard Group’s Neuraxis NRXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$661K Buy
145,562
+73,930
+103% +$221K ﹤0.01% 3881
2025
Q3
$221K Buy
71,632
+43,651
+156% +$111K ﹤0.01% 4111
2025
Q2
$67.7K Hold
27,981
﹤0.01% 4172
2025
Q1
$60.2K Hold
27,981
﹤0.01% 4176
2024
Q4
$65.8K Hold
27,981
﹤0.01% 4193
2024
Q3
$83.4K Buy
27,981
+636
+2% +$1.93K ﹤0.01% 4213
2024
Q2
$76K Buy
27,345
+9,600
+54% +$29.2K ﹤0.01% 4250
2024
Q1
$55.4K Hold
17,745
﹤0.01% 4308
2023
Q4
$47.4K Buy
+17,745
New +$48.1K ﹤0.01% 4376

Other funds holding NRXS

Vanguard Group's NRXS Position: Q4 2025 in Review

Vanguard Group increased its Neuraxis (NRXS) stake by 103% in Q4 2025, buying an estimated $221K and bringing the position to 145,562 shares worth $661K. The position accounts for ﹤0.01% of the portfolio, ranked #3881.

Vanguard Group first reported a position in NRXS in Q4 2023 and has held it in 9 quarters since. 18 funds tracked by Wall St. Rank hold NRXS as of Q4 2025.

  • Vanguard Group held 145,562 shares of Neuraxis worth $661K as of Q4 2025.
  • Vanguard Group bought 73,930 Neuraxis shares in Q4 2025, an estimated $221K.
  • Neuraxis made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3881 holding.
  • Vanguard Group first reported a position in Neuraxis in Q4 2023 and has held it in 9 quarters since.
  • 18 funds tracked by Wall St. Rank held Neuraxis as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.